Clinical forecasting is now leveraging innovative informatics capabilities for more precise recruitment and endpoint projections during a study’s crucial…


FDA rejects Sandoz's Neulasta copy, giving Amgen a break from the biosim onslaught

Sandoz Enbrel biosim cruises at FDA panel, endangering key Amgen sales

FDA staffers like Sandoz' biosimilarity data for copy of Amgen's Enbrel

Sandoz's Enbrel biosim hits its sought-after equivalence mark in psoriasis

Novartis spends on manufacturing, expecting big biosimilar payoff

Novartis' Sandoz aims for 5 biosim launches by 2020

SEC targets biopharma tipster, hedge funders in insider trading suit

Sandoz resumes production at Canada plant after accord reached with union

UPDATED: Sandoz Canada allocates meds after workers strike at Canada plant

Novartis, Mylan eye Teva castoffs worth up to $2B